Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Response to letter regarding article, "Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation".

Kato TS, Collado E, Khawaja T, Kawano Y, Kim M, Farr M, Mancini DM, Schulze PC.

Circ Heart Fail. 2013 May;6(3):e42. No abstract available.

2.

Letter by Bandera et al regarding article, "Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation".

Bandera F, Guazzi M, Arena R.

Circ Heart Fail. 2013 May;6(3):e41. doi: 10.1161/CIRCHEARTFAILURE.112.000050. No abstract available.

3.

Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation.

Kato TS, Collado E, Khawaja T, Kawano Y, Kim M, Farr M, Mancini DM, Schulze PC.

Circ Heart Fail. 2013 Jan;6(1):6-14. doi: 10.1161/CIRCHEARTFAILURE.112.968123. Epub 2012 Nov 30.

4.

Defining and refining heart failure risk stratification to optimize patient selection for cardiac transplantation.

Rogers JG.

Circ Heart Fail. 2013 Jan;6(1):2-3. doi: 10.1161/CIRCHEARTFAILURE.112.973529. No abstract available.

5.

Comparison of plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure.

Williams SG, Ng LL, O'Brien RJ, Taylor S, Li YF, Tan LB.

Am J Cardiol. 2004 Jun 15;93(12):1560-1.

PMID:
15194038
6.
7.

The effect of physical training in chronic heart failure.

Jónsdóttir S, Andersen KK, Sigurosson AF, Sigurosson SB.

Eur J Heart Fail. 2006 Jan;8(1):97-101. Epub 2005 Sep 27.

8.

Comparison of the Degree of Exercise Tolerance in Children After Surgical Treatment of Complex Cardiac Defects, Assessed Using Ergospirometry and the Level of Brain Natriuretic Peptide.

Mazurek B, Szydlowski L, Mazurek M, Markiewicz-Loskot G, Pajak J, Morka A.

Medicine (Baltimore). 2016 Feb;95(8):e2619. doi: 10.1097/MD.0000000000002619.

9.

N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.

Felker GM, Whellan D, Kraus WE, Clare R, Zannad F, Donahue M, Adams K, McKelvie R, Piña IL, O'Connor CM; HF-ACTION Investigators.

Am Heart J. 2009 Oct;158(4 Suppl):S37-44. doi: 10.1016/j.ahj.2009.07.011.

10.

Cardiac response and N-terminal-pro-brain natriuretic peptide kinetics during exercise in patients with COPD.

Wang HY, Xu QF, Xiao Y, Zhang J, Sperry A.

Respir Care. 2011 Jun;56(6):796-9. doi: 10.4187/respcare.00935. Epub 2011 Feb 11.

11.

Response to letter regarding article, "Four-variable risk model in men and women with heart failure".

Horwich TB, Tseng CH, Fonarow GC, Chyu J.

Circ Heart Fail. 2014 Mar 1;7(2):381. No abstract available.

12.

Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure.

Williams SG, Ng LL, O'Brien RJ, Taylor S, Wright DJ, Li YF, Tan LB.

Int J Cardiol. 2005 Jul 10;102(2):279-86.

PMID:
15982497
13.

Elevated brain natriuretic peptide and reduced exercise capacity in adult patients operated on for tetralogy of fallot is due to biventricular dysfunction as determined by the myocardial performance index.

Norozi K, Buchhorn R, Bartmus D, Alpers V, Arnhold JO, Schoof S, Zoege M, Binder L, Geyer S, Wessel A.

Am J Cardiol. 2006 May 1;97(9):1377-82. Epub 2006 Mar 20.

PMID:
16635615
14.

Congenital heart disease, exercise capacity and B-type natriuretic peptide.

Carvalho VO.

Cardiol J. 2009;16(5):489; author reply 490. No abstract available.

PMID:
19753535
15.

Letter by Petretta and Cuocolo regarding article, "Four-variable risk model in men and women with heart failure".

Petretta M, Cuocolo A.

Circ Heart Fail. 2014 Mar 1;7(2):380. doi: 10.1161/CIRCHEARTFAILURE.114.001157. No abstract available.

16.

Optimal Cardiac Resynchronization Therapy Pacing Rate in Non-Ischemic Heart Failure Patients: A Randomized Crossover Pilot Trial.

Ghotbi AA, Sander M, Køber L, Philbert BT, Gustafsson F, Hagemann C, Kjær A, Jacobsen PK.

PLoS One. 2015 Sep 18;10(9):e0138124. doi: 10.1371/journal.pone.0138124. eCollection 2015.

17.

Relation of B-type natriuretic peptide levels before and after exercise and functional capacity in patients with idiopathic dilated cardiomyopathy.

Pascual-Figal DA, Peñafiel P, de la Morena G, Redondo B, Nicolás F, Casas T, Valdés M.

Am J Cardiol. 2007 May 1;99(9):1279-83. Epub 2007 Mar 15.

PMID:
17478157
18.

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure.

Sinha AM, Filzmaier K, Breithardt OA, Kunz D, Graf J, Markus KU, Hanrath P, Stellbrink C.

Am J Cardiol. 2003 Mar 15;91(6):755-8. No abstract available.

PMID:
12633819
19.
20.

Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure.

Passino C, Poletti R, Bramanti F, Prontera C, Clerico A, Emdin M.

Eur J Heart Fail. 2006 Jan;8(1):46-53. Epub 2005 Aug 19.

Supplemental Content

Support Center